Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29588540 | 0.93 | NOD1 (0.53) | NOD1GPR84FFAR1MAPTLCK | |
| SCHEMBL28054290 | 0.90 | GPR84 (0.48) | NOD1GPR84FFAR1MAPTLCK | |
| SCHEMBL30284495 | 0.90 | NOD1 (0.51) | NOD1GPR84FFAR1MAPTLCK | |
| SCHEMBL31414280 | 0.90 | GPR84 (0.48) | NOD1GPR84FFAR1MAPTLCK | |
| SCHEMBL21807140 | 0.86 | FFAR4 (0.51) | NOD1GPR84FFAR1PPARDTDP1 | |
| SCHEMBL29587787 | 0.86 | NOD1 (0.53) | NOD1GPR84FFAR1MAPTLCK | |
| SCHEMBL30992333 | 0.86 | NOD1 (0.53) | NOD1GPR84FFAR1MAPTLCK | |
| SCHEMBL30992334 | 0.86 | NOD1 (0.53) | NOD1GPR84FFAR1MAPTLCK | |
| SCHEMBL9838350 | 0.86 | CHRM1 (0.48) | NOD1GPR84FFAR1MAPTLCK | |
| SCHEMBL25364229 | 0.84 | NOD1 (0.43) | NOD1GPR84FFAR1MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040234470-A1 | Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced effect of optical modifier separate from structured benefit agent | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040234470-A1 | Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced effect of optical modifier separate from structured benefit agent | XPA, LMNA, CFB | NOD1 2288/4885GPR84 1974/4885FFAR1 2448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.